Literature DB >> 9395192

Intra-mesenteric artery steroid administration relieved severe refractory gastro-intestinal graft-vs.-host disease in an allogeneic bone marrow transplantation patient.

T Sato1, S Sakamaki, Y Nagaoka, K Kuribayashi, Y Nagamachi, K Morii, H Honma, K Kogawa, J Kato, Y Niitsu.   

Abstract

We report a case of severe gastro-intestinal (G-I) graft-vs.-host disease (GVHD) successfully treated with intra-mesenteric artery steroid administration. A 29-year-old man with severe aplastic anemia (SAA) was submitted to HLA-identical unrelated allogeneic bone marrow transplantation (BMT) and was found to be suffering from grade IV G-I GVHD. Although cyclosporine, steroid pulse therapy, and FK506 proved ineffective, 30 mg of water-soluble prednisolone as administered into each the superior and inferior mesenteric artery with remarkable effects. This treatment was repeated two times, and the symptoms of G-I GVHD disappeared completely.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9395192     DOI: 10.1002/(sici)1096-8652(199712)56:4<277::aid-ajh14>3.0.co;2-6

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  2 in total

1.  Regional intra-arterial steroid treatment in 120 patients with steroid-resistant or -dependent GvHD.

Authors:  M Y Shapira; A Klimov; S Vipul; S Grisariu; B R Avni; R Or; A I Bloom
Journal:  Bone Marrow Transplant       Date:  2017-06-26       Impact factor: 5.483

2.  Intramesenteric steroid treatment for steroid- refractory gastrointestinal graft versus host disease.

Authors:  Aynur Uğur Bilgin; Pervin Topcuoğlu; Tanzer Sancak; Nahide Konuk; Mutlu Arat
Journal:  Turk J Haematol       Date:  2012-12-05       Impact factor: 1.831

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.